Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.
Partanen A, Waage A, Peceliunas V, Schjesvold F, Anttila P, Säily M, Uttervall K, Putkonen M, Carlson K, Haukas E, Sankelo M, Szatkowski D, Hansson M, Marttila A, Svensson R, Axelsson P, Lauri B, Mikkola M, Karlsson C, Abelsson J, Ahlstrand E, Sikiö A, Klimkowska M, Matuzeviciene R, Fenstad MH, Ilveskero S, Pelliniemi TT, Nahi H, Silvennoinen R. Partanen A, et al. Among authors: mikkola m. Cancers (Basel). 2024 Feb 29;16(5):1024. doi: 10.3390/cancers16051024. Cancers (Basel). 2024. PMID: 38473382 Free PMC article.
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle.
Ruutu T, Koivunen E, Nousiainen T, Pelliniemi TT, Almqvist A, Anttila P, Jantunen E, Koistinen P, Koponen A, Mikkola M, Oksanen K, Pulli T, Remes K, Sarkkinen R, Silvennoinen R, Timonen T, Vanhatalo S, Elonen E; Finnish Leukaemia Group. Ruutu T, et al. Among authors: mikkola m. Eur J Haematol. 2004 Jan;72(1):38-44. doi: 10.1046/j.0902-4441.2003.00182.x. Eur J Haematol. 2004. PMID: 14962261 Clinical Trial.
Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group.
Räty R, Honkanen T, Jantunen E, Jyrkkiö S, Karjalainen-Lindsberg ML, Kuittinen O, Lehto M, Mikkola M, Poikonen E, Rauhala A, Rimpiläinen J, Räsänen A, Siitonen S, Suominen M, Vapaatalo M, Elonen E. Räty R, et al. Among authors: mikkola m. Leuk Lymphoma. 2012 Oct;53(10):1920-8. doi: 10.3109/10428194.2012.672736. Epub 2012 Apr 23. Leuk Lymphoma. 2012. PMID: 22397313 Clinical Trial.
Mechanical forces across compartments coordinate cell shape and fate transitions to generate tissue architecture.
Villeneuve C, Hashmi A, Ylivinkka I, Lawson-Keister E, Miroshnikova YA, Pérez-González C, Myllymäki SM, Bertillot F, Yadav B, Zhang T, Matic Vignjevic D, Mikkola ML, Manning ML, Wickström SA. Villeneuve C, et al. Among authors: mikkola ml. Nat Cell Biol. 2024 Feb;26(2):207-218. doi: 10.1038/s41556-023-01332-4. Epub 2024 Feb 1. Nat Cell Biol. 2024. PMID: 38302719 Free PMC article.
Mesenchyme governs hair follicle induction.
Mäkelä OJM, Mikkola ML. Mäkelä OJM, et al. Among authors: mikkola ml. Development. 2023 Nov 15;150(22):dev202140. doi: 10.1242/dev.202140. Epub 2023 Nov 20. Development. 2023. PMID: 37982496
Molecular and spatial landmarks of early mouse skin development.
Jacob T, Annusver K, Czarnewski P, Dalessandri T, Kalk C, Levra Levron C, Campamà Sanz N, Kastriti ME, Mikkola ML, Rendl M, Lichtenberger BM, Donati G, Björklund ÅK, Kasper M. Jacob T, et al. Among authors: mikkola ml. Dev Cell. 2023 Oct 23;58(20):2140-2162.e5. doi: 10.1016/j.devcel.2023.07.015. Epub 2023 Aug 16. Dev Cell. 2023. PMID: 37591247 Free article.
121 results